52.40
-0.40
(-0.76%)
At close: January 15 at 2:22:12 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-297,615.00
-297,615.00
-275,972.00
-168,684.00
-17.05
Investing Cash Flow
-468,676.00
-468,676.00
-3,146.00
-34,919.00
-7.30
Financing Cash Flow
-3,105.00
-3,105.00
800,000.00
100,000.00
581.11
End Cash Position
278,607.00
278,607.00
1,048,003.00
527,121.00
630.72
Capital Expenditure
-35,414.00
-35,414.00
-2,434.00
-4,914.00
-7.25
Issuance of Capital Stock
--
--
800,000.00
100,000.00
581.11
Free Cash Flow
-333,029.00
-333,029.00
-278,406.00
-173,598.00
-24.30
12/31/2020 - 7/14/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7773.TWO FullHope
43.20
+1.41%
7814.TWO HORIEN
34.65
-6.35%
7790.TWO SSLab
71.80
-0.28%
6999.TWO Han Biomedical
34.70
-4.41%
7808.TWO BIONET TX Corp
46.50
-1.06%
6973.TWO U-Neuron Biomedical Inc
38.35
-3.52%
6986.TWO HeXun Biosciences Co., Ltd.
70.50
-1.12%
6917.TWO Andros Pharmaceuticals Co.,Ltd
18.10
0.00%
7776.TWO Anya
35.85
+1.41%
7729.TWO SBI
21.15
+4.70%